Endothelial progenitor cells in sudden sensorineural hearing loss

Acta Oto-Laryngologica

Volumn 131, Issue 4, 2011, Pages 347-350

  Quaranta, Nicola ^a,d   Ramunni, Alfonso ^b   De Luca, Concetta ^a   Brescia, Paola ^b   Dambra, Porzia ^c   De Tullio, Giacomina ^c   Vacca, Angelo ^c   Quaranta, Antonio ^a  

^a Otology and Neurotologic Surgery   (Italy)

^b Division of Nephrology   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d POLICLINICO   (Italy)

Author keywords

Endothelial dysfunction; flow cytometry; vascular risk factors

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SUDDEN DEAFNESS;

ADULT; ADULT STEM CELLS; AGED; CELL COUNT; FEMALE; FLOW CYTOMETRY; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HUMANS; MALE; MIDDLE AGED;

EID: 79952692820     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016489.2010.536990     Document Type: Article

References (20)

1. Merchant SN, Durand ML, Adams JC. Sudden deafness: is it viral?. ORL J Otorhinolaryngol Relat Spec 2008;70:52-62.
2. Miller J, Dengerink H. Control of inner blood flow. Am J Otolaryngol 1988;9:302-16.
3. Mattox D, Simmons F. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463-70.
4. Ciuffetti G, Scardazza A, Serafini G, Lombardini R, Mannarino E, Simoncelli C. Whole-blood filterability in sudden deafness. Laryngoscope 1991;101:65-7.
5. Ohinata Y, Makimoto K, Kawakami M, Haginomori S, Araki M, Takahashi H. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol 1994;114:601-7. (Pubitemid 24358483)
6. Rudack C, Langer C, Stoll W, Rust S, Walter M. Vascular risk factors in sudden hearing loss. Thromb Haemost 2006;95:454-61.
7. Capaccio P, Ottaviani F, Cuccarini V, Ambrosetti U, Fagnani E, Bottero A, et al. Methylenetetrahydrofolate reductase gene mutations as risk factors for sudden hearing loss. Am J Otolaryngol 2005;26:383-7. (Pubitemid 41578856)
8. Gross M, Friedman G, Eliashar R, Koren-Morag N, Goldschmidt N, Atta IA, et al. Impact of methionine synthase gene and methylenetetrahydrofolate reductase gene polymorphisms on the risk of sudden sensorineural hearing loss. Audiol Neurootol 2006;11:287-93. (Pubitemid 44496282)
9. Quaranta N, Ramunni A, Brescia P, D'Elia A, Vacca A, Ria R. Soluble intercellular adhesion molecule 1 and soluble vascular cell adhesion molecule 1 in sudden hearing loss. Otol Neurotol 2008;29:470-4.
10. Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens 2001;14(6 Pt 2):44S-54S. (Pubitemid 32506696)
11. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7. (Pubitemid 27087709)
12. Dignat-George F, Sampol L. Circulating endothelial cells in vascular disorders: new insight into an old concept. Eur J Haematol 2000;65:215-20.
13. Shantsila E, Watson T, Lip GYH. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 2007;49:741-52.
14. Roberts N, Jahangiri M, Xu Q. Progenitor cells in vascular disease. J Cell Mol Med 2005;9:583-91. (Pubitemid 44159326)
15. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-12. (Pubitemid 36749219)
16. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000;97:3422-7. (Pubitemid 30183318)
17. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-8. (Pubitemid 30062717)
18. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600. (Pubitemid 36204953)
19. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-7. (Pubitemid 40814192)
20. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007. (Pubitemid 41262334)